CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-14 | GIVENS GREGG WM Director | Purchase | +6,000 | $1.30 | $8K | 6,000 |
| 2022-03-14 | GIVENS GREGG WM Director | Purchase | +6,000 | $1.29 | $8K | 6,000 |
| 2022-03-14 | Gilgallon Craig S. EVP & General Counsel | Purchase | +5,975 | $1.38 | $8K | 5,975 |
| 2022-03-14 | Gilgallon Craig S. EVP & General Counsel | Purchase · Warrant to Purchase Common Stock | +5,016 | $0.33 | $2K | 5,016 |
| 2022-03-14 | Callahan Jennifer L. Corporate Controller | Purchase | +12,000 | $1.46 | $17K | 16,543 |
| 2022-03-14 | Callahan Jennifer L. Corporate Controller | Purchase · Warrant to Purchase Common Stock | +1,621 | $0.40 | $652 | 1,621 |
| 2022-03-14 | VAN HORN LOUIS G EVP and CFO | Purchase | +15,000 | $1.34 | $20K | 15,000 |
| 2022-03-14 | Medeiros Curtis Director | Purchase | +17,532 | $1.41 | $25K | 17,532 |
| 2022-02-25 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +12,500 | 12,500 | ||
| 2022-02-25 | Schaffer Shane J. Chief Executive Officer | Grant or award · Stock Option (right to Buy) | +67,500 | 67,500 | ||
| 2022-02-25 | Werth Peter J. Director | Grant or award · Stock Option (right to Buy) | +9,000 | 9,000 | ||
| 2022-02-25 | Hargroves Thomas Jeffrey Director | Grant or award · Stock Option (right to Buy) | +9,000 | 9,000 | ||
| 2022-02-25 | Conroy Jeffrey X Director | Grant or award · Stock Option (right to Buy) | +9,000 | 9,000 | ||
| 2022-02-25 | Medeiros Curtis Director | Grant or award · Stock Option (right to Buy) | +9,000 | 9,000 | ||
| 2022-02-25 | Callahan Jennifer L. Corporate Controller | Grant or award · Stock Option (right to Buy) | +10,000 | 10,000 | ||
| 2022-02-25 | Myers Laurie EVP and COO | Grant or award · Stock Option (right to Buy) | +30,000 | 30,000 | ||
| 2022-02-25 | Gallagher Patrick Joseph Director | Grant or award · Stock Option (right to Buy) | +9,000 | 9,000 | ||
| 2022-02-25 | Silva Raul R. EVP and Chief Science Officer | Grant or award · Stock Option (right to Buy) | +6,000 | 6,000 | ||
| 2022-02-25 | VAN HORN LOUIS G EVP and CFO | Grant or award · Stock Option (right to Buy) | +30,000 | 30,000 | ||
| 2022-02-25 | GIVENS GREGG WM Director | Grant or award · Stock Option (right to Buy) | +9,000 | 9,000 |
Page 9 of 11 · 202 trades